Incentives for drug development--the curious case of colchicine

N Engl J Med. 2010 Jun 3;362(22):2045-7. doi: 10.1056/NEJMp1003126. Epub 2010 Apr 14.

Authors

Aaron S Kesselheim¹, Daniel H Solomon

Affiliation

¹ Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, and Harvard Medical School, Boston, USA.

PMID: 20393164
DOI: 10.1056/NEJMp1003126

No abstract available

Publication types

Historical Article

MeSH terms

Arthritis, Gouty / drug therapy
Colchicine / administration & dosage
Colchicine / therapeutic use*
Drug Approval / history
Drug Discovery / legislation & jurisprudence*
Drug Industry / legislation & jurisprudence
Familial Mediterranean Fever / drug therapy*
Gout / drug therapy*
History, 20th Century
Humans
Legislation, Drug
Orphan Drug Production / history
Orphan Drug Production / legislation & jurisprudence*
Patents as Topic*
United States
United States Food and Drug Administration

Substances

Colchicine